A recombinant Escherichia coll strain was constructed for the overexpresslon of bovine placental lactogen (bPL), using a bPL structural gene containing 9 of the rare arginine codons AGA and AGG. When high level bPL synthesis was induced in this strain, cell growth was Inhibited and bPL accumulated to less than 10% of total cell protein. In addition, about 2% of the recombinant bPL produced from this strain exhibited an altered trypsln digestion pattern. Amino acid residues 74 through 109 normally produce 2 tryptic peptldes, but the altered form of bPL lacked these two peptides and Instead had a new peptlde which was missing arginine residue 86 and one of the two flanking leuclne residues. The codon for arginine residue 86 was AGG and the codons for the flanking leucine residues 85 and 87 were TTG. When 5 of the 9 AGA and AGG codons In the bPL structural gene were changed to more preferred arginine codons, cell growth was not inhibited and bPL accumulated to about 30% of total cell protein. When bPL was purified from this modified strain, which Included changing the arginine codon at position 86 from AGG to CGT, none of the altered form of bPL was produced. These observations are consistent with a model in which translational pausing occurs at the arginine residue 86 AGG codon because the corresponding arginyl -tRNA species is reduced by the high level of bPL synthesis, and a translational hop occurs from the leucine residue 85 TTG codon to the leucine residue 87 TTG codon. This observation represents the first report of an error in protein synthesis due to an in-frame translational hop within an open reading frame.
INTRODUCTION
In Escherichia coli rare codons have been defined as those which appear less than 10% of the time in highly expressed ribosomal genes. Within this group there is a subset of codons that have low levels of their cognate tRNA, and which are called 'rare tRNA codons' (1). Two of these rare tRNA codons are the arginine codons AGA and AGG. The tRNA that recognizes these arginine codons is encoded by the gene argU (2) . The original mutation in the gene that produces this arginyl-tRNA was isolated in a search for genes involved in DNA synthesis (3) , and was designated dnaY. Subsequently, Garcia et al. (4) reported that dnaY encoded this rare arginyl-tRNA species.
These rare arginine codons have also been implicated in ribosomal frameshifting, which has been shown to be involved in the normal translation of a number of genes in E.coli, bacteriophage, and other organisms (5, 6) . In addition, frameshifting has been reported to occur at so-called 'hungry' codons, or codons for which there is a reduced level of their cognate tRNA available at the ribosomal A site (7) . A substrate shortage at a vacant A site results in an error-prone state of the ribosome. Weiss etal. (8) reported +1 ribosomal frameshifting, a one base shift-to the left (or 5') side of the ribosomal A site, at lysine codons when the analog lysine hydroxamate was included in the growth medium. Interestingly, when the 3' overlapping codon was AGA or AGG, no frameshifting was observed. Spanjaard and van Duin (9) reported that a +1 frameshift at tandem AGA or AGG codons was prevented by increasing the copy number of the argU locus.
Robinson et al. (10) reported that the addition of in-frame A-GG codons in the gene encoding chloramphenicol transacetylase reduced the translation rate of the gene. In these studies the chloramphenicol transacetylase gene was placed under the control of the trp promoter on a high copy number plasmid. When 4 AGG codons were inserted, the amount of transacetylase produced in a tryptophan-free defined medium was reduced about 3-fold compared to the amount of enzyme made when the gene contained 4 CGT codons. This difference was not seen in a complex medium, presumably because the trp promoter was partially repressed. Bonekamp et al. (11) and Bonekamp and Jensen (12) suggested that ribosomal pausing occurred at AGA or AGG codons even at low rates of transcription. Differential rates of expression of a pyrE-lacZ fusion were measured after placing 1, 2 or 3 AGG codons in the leader peptide. In this system one AGG codon was sufficient to reduce translation about 2-fold, and each additional AGG codon resulted in further 2-fold reductions in the rates of synthesis.
Brinkmann et al. (13) found a correlation between the number of AGA and AGG codons in highly expressed recombinant genes and the accumulation of their corresponding proteins. They suggested that protein expression would be significantly reduced when the number of AGA and AGG codons exceeded about 3 % of the total number of codons in the gene. The resulting reduction in levels of the charged cognate arginyl-tRNA was so severe in some hosts that the optical density of the culture did not increase after induction of recombinant protein synthesis, although the recombinant protein accumulated to about 5 % of total cell protein. When the argU gene was present on a compatible highcopy number plasmid, both optical density and product accumulation continued to increase after induction of recombinant protein synthesis.
In this report we describe a novel in-frame two codon translational hop associated with the translation of AGG codons in E.coli K-12. While similar in-frame translational hops have been reported to occur over stop codons (14, 15) , this report is the first description of an error in protein synthesis due to an in-frame translational hop within an open reading frame. This observation adds translational hops to the growing list of mistranslation events associated with overexpression of proteins in E.coli. [pMON3922] were grown in 10 liter fermenters as described (17) , and bPL synthesis was induced by the addition of 50 ng per ml nalidixic acid. Cells were homogenized and inclusion bodies of bPL were collected by centrifugation. Preparative reverse phase HPLC was carried out with a Perkin-Elmer Series 4 HPLC equipped with a Perkin-Elmer ISS100 autosampler and an HP 1040 UV detector at 280 nm. Refolded bPL was applied to a Vydac C4 column equilibrated with 40% acetonitrile and 25 mM trifluoroacetic acid. The material was eluted with a linear gradient of 40% to 47.5% acetonitrile containing 25 mM trifluoroacetic acid over 30 minutes at 1 ml per min. Repetitive cycles were run for each construct in order to collect several samples of the early eluting bPL species. The fractionated components were pooled, dehydrated and recycled to confirm purity and estimate quantity. Each purified early eluting pool was essentially free of the major bPL species.
MATERIALS AND METHODS

Growth and induction conditions
Peptide mapping of bPL bPL was dissolved at 2 mg per ml in 0.1 M Tris-Cl, pH 7.5. Trypsin was added to a final concentration of 0.04 mg per ml and the samples were incubated at 22°C for 14.5 hours. At the end of this time the samples were lowered to pH 3.0 by the addition of 1 N HC1 and kept on ice until analyzed. The peptides were separated by reverse phase chromatography using a PerkinElmer Series 4 HPLC equipped with a Perkin-Elmer ISS100 autosampler and Kratos 783 LTV detector at 210 nm. A 30 y\ sample was injected onto a Nucleosil C18 colunm (Alltech 89141) equilibrated in 15 mM trifluoroacetic acid. The peptides were eluted from this column using acetonitrile linear gradients of 0-11% over 16min, 11-23% over30min, 23-49% over26 min, and 49-75% over 2 min. The flow rate was 1.5 ml per min.
Amino acid sequencing
Automated Edman degradation chemistry was performed with an Applied Biosystems Inc. (Foster City, CA) model 470A gas phase sequenator. The respective, PTH-amino acid derivatives were identified by reversed-phase HPLC with an Applied Biosystems Inc. model 120A PTH analyzer equipped with a Brownlee 2.1 mm PTH-C18 column. The elution time of the PTH-amino acid for each cycle was compared to PTH-amino acid standards (obtained as a kit from Applied Biosystems, Inc.) in order to identify the amino acid at each cycle.
Mutagenesis and cloning
The rare arginine codons at positions 35, 38, 86, 109, and 119 in the bPL gene were changed to E. co/i-preferred arginine codons (18) by using a polymerase chain reaction procedure (19) . Briefly, synthetic oligonucleotides encoding the changes were used to amplify portions of the bPL gene and these PCR products were then combined for further amplification to eventually form the new bPL gene with the desired changes. DNA sequencing of the gene was used to confirm the changes made.
Electrospray mass spectrometry
Samples containing approximately 500 fig of bPL were desalted by HPLC, and then evaporated to dryness. The protein was dissolved in water:methanol:formic acid (50:50:1, v:v:v) to a final concentration of 20 pmol//d, and 25 /tl of this solution injected into a Sciex API HI triple-quadrupole mass spectrometer (Sciex, Inc., Toronto). Twenty scans were averaged to obtain the mass spectra used for this study. The average molecular weights of the normal and modified species of bPL were calculated from the multiply protonated ions in the mass spectrum.
RESULTS
E.coli K-12 strain MON105 contains an rpoH mutation which enhances the accumulation of heterologous proteins (20) . It is a wild-type strain in all other respects, including all of the components required for translation. Strain MON105 was transformed with pMON3403, a plasmid with the bPL gene under the control of the recA promoter. The nucleotide sequence of the bPL structural gene on pMON3403 differs from that in GenBank (accession no. J02840) at four positions. Codons 1 and 2, which are normally alanine GCG and glutamic acid GAG, were intentionally altered to alanine GCA and glutamic acid G-AA, respectively, to facilitate high-level expression in E.coli. At codon 58, which is phenylalanine TTC in the GenBank sequence, we found valine GTC instead. At codon 84, which is leucine CTG in the GenBank sequence, we found leucine C-TC instead. These latter two differences may be due to polymorphisms in the bPL gene. After the addition of the recA inducer nalidixic acid, high level synthesis of bPL was initiated, resulting in the formation of inclusion bodies containing bPL. When a culture of MON105 [pMON3403] was induced with nalidixic acid, there was only a 75 % increase in the optical density of the culture. With such production systems, increases in optical density are due not to increases in cell number as much as increases in cell size and the formation of inclusion bodies (21, 22, 23) . The cells and inclusion bodies in this strain were examined with the aid of computer enhanced image analysis. n. increase in cell size, low percentage of cells with inclusion bodies, and relatively small inclusion bodies, explains why the optical density of the culture increased by less than two-fold after induction. These physiological responses, namely a low accumulation of product and an inhibition of cell growth, have been observed in other E. coli systems with highly expressed heterologous genes containing the arginine codons AGA or AGG at levels greater than 3% of the total number of codons (13) . Both of these effects were attributed to high level expression of such genes resulting in a correspondingly high demand for the cognate arginyl -tRNA. The bPL structural gene employed in the studies described above contained 12 arginine codons, 9 of which were AGA or AGG. This represented 4.5% (9 out of 200) of the codons in the bPL structural gene, and thus could be responsible for the observed physiological problems. In order to test this hypothesis, 5 of the 9 AGA and AGG arginine codons were changed to the more preferred arginine codons CGT or CGC, lowering the content of AGA and AGG codons to 2%. These modified arginine codons were placed at positions 35 (CGT), 38 (CGC), 86 (CGT), 109 (CGT), and 119 (CGC). The plasmid with this modified bPL structural gene was designated pMON3922. When strain MON105 [pMON3922] was induced with nalidixic acid, the optical density of the culture more than doubled, and about 93% of the cells contained inclusion bodies. These inclusion bodies had an average mean area of about 0.9 /xm 2 , which was approximately 4.5-fold larger than those found in MON105 [pMON3403].
Purified bPL prepared from both MON105 [pMON3403] and MON105 [pMON3922] was subjected to reverse phase HPLC. In each case two monomeric species of bPL were observed ( Figure 1) ; both species from each strain were characterized by tryptic mapping. The early eluting species represented about 20% of the total bPL made by each strain. However, about 10% of this early eluting material (that is, about 2% of the total bPL produced) obtained from MON105 [pMON3403], the strain with the unmodified bPL structural gene, contained a new tryptic peptide (Figure 2 
) with the sequence E-A-A-A-N-T-E-D-E-A-L-L 85 -V 88 -I-S-L-L-H-S-W-D-E-P-L-H-Q-A-V-T-E-L-L-H-R (Figure 3). This sequence was identical to two other tryptic fragments found in the major bPL species, E-A-A-A-N-T-E-D-E-A-L-L^-R and L-V^-I-S-L-L-H-S-W-D-E-P-L-H-Q-A-V-T-E-L-L-H-R
, except that 2 amino acids, arginine residue 86 and one of the flanking leucine residues, were missing (the absence of arginine at position 86 prevents trypsin from digesting this peptide). The early eluting bPL species from MON105 [pMON3922], the strain with the five altered arginine codons, did not contain the new tryptic peptide (data not shown).
Electrospray mass spectrometry was used to confirm that from the strain with the unmodified bPL structural gene, a significant amount of the early eluting species of bPL was missing the residues arginine and leucine (data not shown). This analysis indicated a molecular mass of 22,988 daltons for normal bPL. Analysis of the early eluting species of bPL also yielded a mass of 22,988 daltons, but approximately 10% of this fraction was composed of a bPL species with a molecular mass of 22,718 daltons. This loss of 270 daltons is that expected from a bPL molecule missing an arginine residue (156 daltons) and a leucine residue (113 daltons). Analysis of the early eluting species of bPL from the strain with the altered arginine codons did not reveal any of the 22,718 dalton species of bPL. The first pand is die chromatogram from a set of amino acid standards, used to identify the amino acid at each cycle. The peaks labelled 1 and 2 in this panel correspond to N,N-dimethyl-N-pheoylmiourea and dipnenylthiourea, respectively, which were included in the amino acid standards kit These compounds are common by-products of die sequencing reactions, and appear as peaks in the subsequent chromatograms. Figure 4 . Context of the nine rare arginine codons within the bPL structural gene on pMON3403, the plasmid in the unmodified strain exhibiting the translational hop. Only the 5'-3' strand is shown, with the corresponding amino acid sequence given above the nucleotide sequence. The position of each rare arginine residue is indicated by the number above the amino acid sequence.
DISCUSSION
Overexpression in E. coli of bPL encoded by a structural gene with a high content of the rare arginine codons AGA and AGG resulted in several interesting effects. Growth of the strain and total production of bPL were significantly lower when compared to an isogenic strain using a bPL structural gene with fewer of the rare arginine codons. These effects have been described previously for proteins encoded by genes with more than 3% of their codons being AGA or AGG (13) ; in the case of the bPL structural gene employed in these studies, AGA and AGG represented 4.5% of the total codons. In addition, we observed an unexpectedly high rate of mistranslation at the AGG codon 86. About 2 % of the bPL encoded by the structural gene high in the AGA and AGG codons was missing arginine residue 86 and one of the flanking leucine residues. This in-frame deletion of 2 amino acids is most easily explained by a translational hop associated with the AGG codon 86. Presumably, the overexpression of a gene high in AGA and AGG codons would result in a high demand for the rare cognate arginyl-tRNA for those codons. This could in turn result in ribosomal pausing at this starved codon, with the associated peptidyl -tRNA remaining bound to the leucine residue 85 TTG codon. Codon 87 on the bPL structural gene is also a leucine TTG codon (Figure 4 ). For the observed two codon translational hop to occur, we suggest that the peptidyl-tRNA dissociated from codon 85 and reassociated with codon 87, exposing the valine residue 88 codon GTT to the A site of the paused ribosome, and allowing protein synthesis to continue from that point. Thus, both the arginine residue 86 AGG codon and the leucine residue 87 TTG codon would be skipped, with the net result being a loss of 2 amino acids (Figure 4) . Reducing the number of AGA and AGG codons from 4.5 % to 2 % eliminated the observed physiological effects, resulting in increased cell growth and accumulation of bPL. Furthermore, in this modified gene the arginine codon at position 86 was changed from AGG to CGT. When bPL produced in this modified strain was examined, no species was found containing the two codon translational hop.
The in-frame translational hop within an open reading frame (i.e., not over a stop codon) described here represents the first report of such an error in protein synthesis. However, this type of translational hop may be a relatively frequent event which is simply difficult to detect. There are many earlier reports of other, easier to detect, types of translational hops which show many similarities to the hop described here. The closest examples are those of translational hops over stop codons. This was first reported by Weiss et al. (14) and O'Connor et al. (24) , who described both in-frame and frameshifted hops over stop codons. This included a two codon hop at the sequence CTT-TAG-C-TA-CGA (encoding Leu-STOP-Leu-Arg), which was decoded as Leu-Arg about 1 % of the time. This result is very similar to that described in this report, with a codon and one of its flanking leucine codons being skipped by the hop. We observed that the sequence TTG-AGG-TTG-GTT (encoding Leu-Arg-Leu-Val) was decoded as Leu-Val about 2% of the time. It has been suggested that translational hops at stop codons are due to slow decoding of the stop codon (15) ; the same mechanism may be at work in hops involving pausing at starved sense codons such as the rare arginine codon implicated in the hop described here. All of these observations were made in cells with wild-type translational components. Translational hops have also been observed in strains with certain tRNA mutations (24, 25) , including a two codon hop at the sequence GTG-TAA-GTT-AGC (encoding Val-STOP-Val-Ser), which was decoded as Val-Ser in a strain with a valine tRNA mutation. Again, there are striking similarities to the hop described in this report, with the stop codon and one flanking valine codon being skipped by the hop. While the underlying structural features essential to a hop site are not yet completely defined, it appears that translational hops require a 'takeoff site' and a similar 'landing site' (5); in the hop described in this report, the leucine codons at positions 85 and 87 are apparently acting as these sites.
There are two examples of much more efficient translational hops, both occurring during the normal expression of a gene rather than as an error in protein synthesis. These types of translational hops also show certain similarities to the hop described here. Weiss et al. (26) showed that in the essentially 100% efficient 50 bp hop within the bacteriophage T4 toposiomerase gene 60 (27) , there are absolute requirements for duplicated GGA codons in the nucleotide sequence bordering the hop she and a ciy-acting nascent polypeptide within the ribosome. Wong and Abdelal (28) found an apparently 100% efficient 12 bp hop within the Pseudomonas aeruginosa carbamoylphosphate synthetase carA gene when expressed in either the parent organism or in E.coli, with the sequence GCC-ACT-ACG-CCA-GCC-ATT (encoding Ala-Thr-Thr-Pro-Ala-Ile) decoded as AlaIle. In this example, the alanine codons may be acting as takeoff and landing sites for the translational hop, although the threonine ACT codon is a preferred rather than a rare codon. This fact plus the high efficiency of the translational hops in these two examples suggests that they may employ a different mechanism than that at work in the reading frame error associated translational hops described above.
Recombinant E. coli strains engineered to overproduce proteins have been observed to exhibit a variety of types of increased mistranslation, including misincorporation of natural and unnatural amino acids, frameshifting, and readthrough of stop codons (17, 29, 30, 31) . The observations described here add translational hops to this list of mistranslation events associated with protein overexpression in E. coli. The level of mistranslation in recombinant systems seems to be dependent on the amino acid composition of the protein being overexpressed, the codons utilized in the structural gene for that protein, and the composition of the culture medium. The successful exploitation of E. coli and other organisms for the production of high-quality proteins for both research and commercial purposes depends on a more detailed understanding of overproduction-related processes such as mistranslation. The major technical obstacle to acheiving this goal is the difficulty in detecting mistranslation events, especially in large polypeptides. The type of translational hop described in this report may be relatively widespread, having simply escaped detection until now. Recognition of the types and causes of mistranslation will enable guidelines to be established aimed at minimizing such events.
